Literature DB >> 11279649

Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma.

K Oshima1, Y Kanda, Y Nannya, M Kaneko, T Hamaki, M Suguro, R Yamamoto, A Chizuka, T Matsuyama, N Takezako, A Miwa, A Togawa, H Niino, M Nasu, K Saito, T Morita.   

Abstract

We studied clinical features and pathologic findings in 52 consecutively autopsied patients with multiple myeloma in our center between 1979 and 1998. Distant extraosseous involvement was found in 33 patients (63.5%). Thirty-one patients (59.6%) were proven to have infection at autopsy, among which pneumonia was most common site of infection. Amyloidosis was shown in 8 patients. Second malignancies were observed in 4 cases. The three major causes of death were hemorrhage, infection, and renal failure, which accounted for death in approximately 70% of the patients. Advances in the anticancer and antimicrobial chemotherapies might have decreased deaths due to myeloma itself or infection. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11279649     DOI: 10.1002/ajh.1067

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  26 in total

1.  Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.

Authors:  Sachin S Saboo; Fiona Fennessy; Lina Benajiba; Jacob Laubach; Kenneth C Anderson; Paul G Richardson
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

Review 2.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

3.  Three cases of synchronous solid tumor and multiple myeloma.

Authors:  Sang Hoon Ji; Joon Oh Park; Jeeyun Lee; Mi Jung Oh; Do Hyoung Lim; Byeong-Bae Park; Keun Woo Park; Se-Hoon Lee; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Mark H Lee; Keunchil Park
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

4.  Renal failure caused by plasma cell infiltration in multiple myeloma.

Authors:  Shiho Hanawa; Tetsu Akimoto; Eisuke Uehara; Makoto Inoue; Toshimi Imai; Atsushi Kotoda; Hiromichi Yoshizawa; Tomohiro Matsuyama; Masuzu Ueda; Osamu Saito; Yoshitomo Hamano; Wako Yumura; Keiya Ozawa; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

5.  Spleen in haematological malignancies: spectrum of imaging findings.

Authors:  S S Saboo; K M Krajewski; K N O'Regan; A Giardino; J R Brown; N Ramaiya; J P Jagannathan
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

6.  CT features of abdominal plasma cell neoplasms.

Authors:  J Monill; J Pernas; E Montserrat; C Pérez; J Clavero; A Martinez-Noguera; R Guerrero; S Torrubia
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

7.  An Unusual Cause of Altered Mental Status in Multiple Myeloma: An Extraosseous Manifestation.

Authors:  Veeravich Jaruvongvanich; Ittikorn Spanuchart; Pichaya O-Charoen; Christian Kitamura; Lauren Sumida; Marina Roytman
Journal:  Hawaii J Med Public Health       Date:  2016-04

8.  Nodular liver lesions involving multiple myeloma: a case report and literature review.

Authors:  Xiao-Ning Wu; Xin-Yan Zhao; Ji-Dong Jia
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

9.  Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival.

Authors:  Takayoshi Kiba; Takuo Ito; Toshihisa Nakashima; Yoshiko Okikawa; Miki Kido; Akiko Kimura; Keita Kameda; Fumiaki Miyamae; Suzuko Tanaka; Misao Atsumi; Yoko Sumitani; Yoshimi Shitakubo; Hiromasa Niimi
Journal:  BMC Cancer       Date:  2014-06-21       Impact factor: 4.430

10.  Relapse of multiple myeloma presenting as extramedullary plasmacytomas in multiple organs.

Authors:  Murat Köse; Ersida Buraniqi; Timur Selçuk Akpinar; Seyit Mehmet Kayacan; Tufan Tükek
Journal:  Case Rep Hematol       Date:  2015-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.